http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6511834-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
filingDate | 2000-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0f6da2d10b6cd1bfd5d5dc82e76eb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a00329bb08db5be13eb6b75c00026c8 |
publicationDate | 2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-6511834-B1 |
titleOfInvention | 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor |
abstract | The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004014666-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006204600-A1 |
priorityDate | 2000-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2984.